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The need for molecular tools for the differentiation of isolates of Mycobacterium leprae, the organism that
causes leprosy, is urgent in view of the continuing high levels of new case detection, despite years of aggressive
chemotherapy and the consequent reduction in the prevalence of leprosy. The slow onset of leprosy and the
reliance on physical examination for detection of disease have restricted the epidemiological tracking necessary
to understand and control transmission. Two genetic loci in several isolates of M. leprae have previously been
demonstrated to contain variable-number tandem repeats (VNTRs). On the basis of these reports and the
availability of the full genome sequence, multiple-locus VNTR analysis for strain typing has been undertaken.
A panel of 11 short tandem repeat (STR) loci with repeat units of 1, 2, 3, 6, 12, 18, 21, and 27 bp from four
clinical isolates of M. leprae propagated in armadillo hosts were screened by PCR. Fragment length polymor-
phisms were detected at 9 of the 11 loci by agarose gel electrophoresis. Sequencing of representative DNA
products confirmed the presence of VNTRs between isolates. The application of nine new polymorphic STRs
in conjunction with automated methods for electrophoresis and size determination allows greater discrimi-
nation between isolates of M. leprae and enhances the potential of this technique to track the transmission of
leprosy.
The World Health Organization and its partners created the
Global Alliance for Leprosy Elimination in 1999 with the aim
of achieving the elimination of leprosy by the end of the year
2005, a goal originally set for the year 2000 (http://www.who
.int/inf-pr-1999/en/pr99-70.html). Leprosy is effectively con-
trolled by a multidrug therapy (MDT) regimen composed of
dapsone, rifampin, and clofazimine. However, continuing large
numbers of new cases are being detected in areas of the world
where the disease is highly endemic, despite the application of
the MDT program since 1982 (36). In order to comprehend
this rising incidence of leprosy, it is necessary to identify the
natural reservoir of Mycobacterium leprae, the route of infec-
tion, and the mode of its transmission. It is commonly believed
that the human is the host and reservoir of M. leprae and that
successful MDT will eliminate leprosy. However, other modes
of transmission involving nonhuman reservoirs, such as soil (6,
15), water (20), vegetation (16), animals (including armadillos
and sooty mangabeys) (22, 33), and arthropods (fleas, ticks,
mosquitoes, and flies), have been suggested, as reviewed by
Blake et al. (3). The route of infection is also unknown, al-
though the entry and the exit of the bacteria via the nasal
passages have been proposed (9). Methods that specifically
detect M. leprae DNA in nasal swabs are being developed with
the aim of early detection in populations at the community and
village levels and for the monitoring of leprosy transmission
(13, 23). Typing methods for distinguishing cases of relapse
from new infections are also required. Molecular typing will
make it feasible to study the global and geographical distribu-
tions of distinct clones of M. leprae, explore correlations be-
tween the M. leprae genotypes and the incidence rates of lep-
rosy, and the type of disease manifestation (tuberculoid versus
lepromatous) and provide some insight into the historical and
phylogenetic evolution of the bacillus that has affected humans
and stigmatized leprosy patients for centuries. The research
community has been urged to develop molecular typing meth-
ods to complement the efforts of clinicians and health care
workers (10, 25). These points have been emphasized in a
recent review (38), which provided an elegant perspective of
the general methods available for typing mycobacteria, partic-
ularly M. tuberculosis, and their relevance to M. leprae.
Approaches to uncovering polymorphisms attributed to sin-
gle nucleotide mutations, insertion elements, and variable-
number tandem repeats (VNTRs) in the mycobacterial inter-
spersed repetitive unit loci in a panel of M. leprae strains have
not identified any molecular typing markers (8, 35). However,
it has been possible to recognize other potential polymorphic
sites from the genome sequence of M. leprae (8). As is the case
in several eukaryotic and prokaryotic genomes that have been
sequenced, short stretches of DNA that occur in tandem re-
peats are found in M. leprae (8, 30, 32).
Matsuoka et al. (21) first reported that a 6-bp sequence was
found as two alleles in the rpoT gene of M. leprae. This was
followed by the recognition of VNTRs of the TTC triplet in an
intergenic region of the genome (26). Both sets of VNTRs
have been used in the first applications of genotyping to M.
leprae isolates. In the study described in this paper, we have
identified nine additional polymorphic loci in a small set of
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four armadillo-derived M. leprae isolates and demonstrate
their applicability to distinguish between isolates of M. leprae
by the use of multiple-locus VNTR analysis (MLVA).
MATERIALS AND METHODS
M. leprae DNA isolation. Clinical isolates of M. leprae passaged in an armadillo
were obtained from Richard W. Truman, National Hansen’s Disease Program,
Louisiana State University, Baton Rouge, in the form of infected livers and
spleens. The isolates used in this study are designated 4089, 4264, 4923, and
Thai-53. About 20 g of tissue was processed as described by Lloyd and Draper
(19) to obtain approximately 100 mg of purified M. leprae cells (containing, on
average, 2.9  109 bacilli/mg). DNA was extracted from the purified M. leprae
cells by methods developed for mycobacteria in general (1).
Biopsy samples collected from previous studies and stored at 70°C were
processed for DNA as described in those studies (26, 37). Briefly, thin sections
5 m thick were cut with a cryostat microtome and distributed into several
cryovials, each of which contained 10 sections. DNA for PCR amplification of
M. leprae sequences was obtained by breakage with 0.1-mm-diameter zirconium
beads in the presence of Tris-EDTA buffer (TE) and a mixture of phenol,
chloroform, and isoamyl alcohol. The extract was centrifuged, and the aqueous
phase was boiled for 10 min before the DNA was precipitated with ethanol. The
final DNA (10 l in TE) was used as the template for one PCR.
Primer selection. Primer sets for the amplification of regions of DNA con-
taining the short tandem repeat (STR) sites were identified by using Oligo 6
Primer Analysis software (Molecular Biology Insights, Inc., Cascade, Colo.). A
tract of 400 to 500 bp that included the STRs was screened for primers (18 to 21
bases long) with melting temperatures (Tms) between 55 and 65°C and a GC
content near 50% to produce PCR products with lengths in the range of 150 to
400 bp (Table 1). Primer pairs that could form dimers and hairpin interactions
were avoided.
PCR amplification of STRs. The PCR mixture consisted of Platinum PCR
SuperMix (Invitrogen Corporation, Carlsbad, Calif.), which contains Platinum
Taq polymerase, deoxynucleoside triphosphates, and buffer; 200 nM (each) prim-
er; and 500 ng of M. leprae genomic DNA. Following an activation step at 94°C
for 2 min, 10 cycles of touchdown PCR were performed with a model 9600
Thermocycler (Perkin-Elmer Co., Norwalk, Conn.), in which the annealing tem-
perature was reduced from 65 to 55°C at a rate of 1°C per cycle. After the
touchdown phase, 25 additional cycles were run at an annealing temperature of
55°C. The PCR was terminated with a final extension at 72°C for 5 min. An
aliquot of the reaction mixture was run on a 3% agarose gel. For direct sequenc-
ing of the PCR products, the reaction products were purified on a Qiaquick Spin
Column (Qiagen, Valencia, Calif.).
Microsatellite MLVA with the ABI PRISM 3100 Genetic Analyzer and Gen-
eMapper. The forward primers (Table 1) for the (AT)17, (AGA)20, and 21-3 loci
[where the locus designations indicate (repeat unit sequence)number of repeats,
followed by a letter, if needed, or the length of the repeat-number of repeat units,
followed by a letter, if needed] were labeled with PET, NED, and 6-FAM
fluorescent dyes at the 5 termini, while the primers for the 6-7 and 12-5 loci were
labeled with VIC (Applied Biosystems, Foster City, Calif.). Following separate
PCRs with the forward fluorescent labeled primer and the unlabeled reverse
primer, as described above, 1 l [8 l for (AT)17] of each product was combined
in a volume of 100 l. A 1-l aliquot of this sample was mixed with 12 l of
formamide and 0.5 l of GeneScan 500LIZ (Applied Biosystems) sizing stan-
dards. The sample was denatured at 94°C for 5 min and cooled prior to electro-
phoresis on an ABI PRISM 3100 Genetic Analyzer under denaturing conditions
on a 36-cm capillary column with performance-optimized polymer 4 polymer
(Applied Biosystems) at 60°C. The instrument was previously calibrated with
DS-33 matrix standards (Applied Biosystems). The electrophoresis data were
analyzed with GeneMapper software (Applied Biosystems). These analyses were
carried out at the Macromolecular Resources Laboratory, Colorado State Uni-
versity.
RESULTS
The goal of this study was to launch a systematic approach to
the identification of polymorphic genetic loci applicable for the
tracking of leprosy. Two elements were required for this study:
target loci and a panel of distinct isolates. M. leprae strains are
not cultivable in the laboratory, as extreme genome downsizing
has resulted in an obligate intracellular niche (7). For research
applications, M. leprae is obtained by propagating isolates in a
susceptible armadillo host (28) or nude mice (31), principally
at the National Hansen’s Disease Program. The long doubling
time of 12 to 14 days also affects the availability of M. leprae
(18). Although small amounts of M. leprae for PCR applica-
tions can be obtained from biopsy specimens, slit skin smears,
and the nasal mucus of leprosy patients, for these studies we
found it more feasible and practical to study several loci in a
limited set of available armadillo-derived isolates. Our goal
was to uncover and validate polymorphic loci and also to stan-
dardize methods for MLVA before their application to clinical
samples. The number of repeat units at different loci in the
sequenced M. leprae TN strain was used as a reference with
which to compare the number of repeats in the four test iso-
lates. All STR loci that had different numbers of tandem re-
peats in at least one isolate compared to the sequence of the
TN strain were considered polymorphic and potentially useful
for typing.
Selection of potential VNTR loci. The M. leprae genome
sequence is now in the public domain, and all potential poly-
morphic sites can be selected by in silico analysis. Using the
Search Pattern Program within the Leproma website (14), the
Tandem repeats finder (2), and MICdb 1.0 database (27), we
interrogated the M. leprae TN genome for simple nucleotide
repeats. There were more than 100 STRs with at least two
repeat units. To streamline the screening process, we used a
cutoff of eight repeats for single nucleotides, six repeats for
TABLE 1. Primers used in the PCR amplification of STR loci





(C)20 5-TCGGCGACTGCGGTAACATT-3 62 5-CGAGTGAGCGGAACGGAGTA-3 60 197
(TA)18 5-CGTGCGTCGTGTGTAGGCA-3 62 5-GACGTGGCAACATCGAAGTT-3 60 230
(AT)17 5-TCTCCAACATGCTGCGACA-3 60 5-GTACAGCGGCCTGATCGAA-3 60 181
(CG)6 5-CAATTCTCCGCGCCGATGA-3 60 5-CGGACTTAGTGCGTGCGAT-3 60 211
(AC)9 5-AGCGCCCGTTGTCGATAGA-3 60 5-TGCTGGTGACCCGCGATA-3 58 236
(GTA)9 5-AGCCTTAGTCGCGCAGATG-3 60 5-TCCGCTGTCCGTCCGCTGA-3 64 307
(AGA)20 5-GGACCTAAACCATCCCGTTT-3 62 5-CTACAGGGGGCACTTAGCTC-3 64 201
6-7 5-GCCATCGTTGTCGGTTCATC-3 62 5-CGGAGGAGGTGGGTACGGT-3 64 268
12-5 5-CTGGTCCACTTGCGGTACG-3 62 5-GGAGAAGGAGGCCGAATACA-3 62 289
18-8 5-GCCCGTCTATCCGCATCAA-3 60 5-GCAAAGATCAGCACGCCAAT-3 60 348
21-3 5-GAATCTGACCTTTCGGAAATG-3 60 5-CGATGCAGCTTCCTACGG-3 58 312
27-5 5-ATTGAGCAGATGGCCGGTC-3 60 5-AGCAGTCGGCACGCCCTT-3 60 327
a As for the M. leprae TN strain (14).
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dinucleotide sequences, and five repeats for trinucleotide se-
quences to arrive at 33 promising loci for use in typing studies
(Table 2). For longer repeat units (5 bp), we selected 11 loci
with at least three tandem repeats (Table 3). Our premise was
that the degree of allelic diversity at a locus is likely to be
higher when the number of repeat units is high. Almost all of
the STRs fall within intergenic regions or within pseudogenes
and are therefore unlikely to disrupt any biological pathways.
A few of the STRs, particularly the minisatellites, are within
genes. The primer sets used for PCR amplification (Table 1)
TABLE 2. Microsatellites in M. leprae TN genome targeted for MLVAa
Repeat
unit (bp) Locus ID
b Coordinates Intergenic region Intragenic region/gene orientation
1 (T)8, (A)6 337466–337473, 337474–337479 ML0258-ML0259
1 (T)6, (N)7, (T)8 514181–514186, 514187–514193, 514194–5141101 ML0415/
1 (A)9 1414666–1414674 ML1196-ML1197
1 (G)9 976857–976865 ML0823/
1 (C)9 2658192–2658200 ML2238/
1 (G)10a 347280–347289 ML0266/
1 (G)10b 442993–443002 ML0350/
1 (G)11 1309544–1309554 ML1126/
1 (G)12 1116443–1116454 ML0946/
1 (C)16(G)8 1987156–1987171, 1987172–1987179 ML1647-ML1648
1 (C)20c 312039–312058 ML0237-ML0238
1 (G)22 229625–229646 ML0164/
2 (CG)6c 2947291–2947302 ML2472/
2 (AC)8a 1531185–1531200 ML1285/
2 (AC)8b 2211035–2211050 ML1824-ML1825
2 (AC)9c 1452573–1452590 ML1227-ML1228
2 (CA)6 2507097–2507108 ML2106-ML2107
2 (TA)8 3221617–3221632 ML2676-ML2677
2 (TA)9 2844971–2844988 ML2375-ML2376
2 (TA)10 1744091–1744110 ML1450-ML1451
2 (TA)13 308815–308840 ML0235-ML0236
2 (AT)10 2951821–2951840 ML2476-ML2477
2 (AT)15 948935–948964 ML0798-ML0799
2 (AT)17c 2597735–2597768 ML2183/
2 (TA)18c 984591–984626 ML0830/
3 (ACC)5 1980049–1980063 ML1645/
3 (GGT)5 2567251–2567265 ML2159-MI2160
3 (AGT)5a 1237528–1237542 ML1073/
3 (AGT)5b 1293503–1293517 ML1118/
3 (ACT)5 2656108–2656122 ML2236/
3 (GTA)9c 2583814–2583840 ML2172-ML2173
3 (AGA)20c 2785435–2785494 ML2344-ML2345
5 (CACCG)3 2562391–2562405 ML2158-ML2159
a The coordinates, repeat unit sequence, number of repeat units, and the gene numbers are as for the M. leprae TN genome sequence (14). Pseudogenes are underlined.
b For easy reference, the locus identification (ID) is (repeat unit sequence)number of repeats, followed by a letter, if needed. The (AGA)20 repeat locus is the same as the
TTC locus described previously (26).
c The loci analyzed in this report.





(Consensus sequence of unit)
number of unitsc Intergenic region
Intragenic/gene
orientation
6-3a 6 1190341–1190358 (TCGATG)3 ML1022/
6-3b 6 2302531–2302548 (GATCAC)3 ML1918/
6-7d 6 1816857–1816892 (GCACCT)7 ML1505/
7-3 7 285076–285096 (GCGTGCC)3 ML0213/
10-4 10 1139035–1139074 (ttATTAATAA)4 ML0970/
12-5d 12 1381661–1381723 (GAGGTTGTTGAG)5 ML1182/
15-3 15 2928131–2928175 (CCTTCTTgGCcGGaG)3 ML2454-ML2455
18-8d 18 1587619–1587763 (GGCcCGCCTGGCCAGTAC)8 ML1334/
21-3d 21 73077–73139 (CAAGCCAGGAATCAAGTTGAT)3 ML0058/
23-3 23 2945487–2945555 (ATAATACTGTAGTGAACGACATC)3 ML2469-ML2470
27-5d 27 687026–687160 (CCGGTGGTGcCGCCTGGTGGGTTTCcC)5 ML0568/
a The coordinates, consensus sequence, number of repeat units, and the gene numbers are as for the M. leprae TN genome sequence (14). Pseudogenes are underlined.
b Each locus was given an identification (ID) for easy reference (length of repeat-number of repeats, followed by a letter, if needed). The 6-3a locus has been studied
previously (21). The 21 bases upstream of the 21-3 locus are homologous to the repeat and could form a fourth repeat.
c A lowercase letter in a consensus sequence is a nonconserved base in tandem repeats.
d The loci analyzed in this report.
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were chosen as described in the Materials and Methods sec-
tion.
VNTR polymorphism at five minisatellite loci. We began
with five loci that have more than two repeats in the TN strain.
For screening of this set of loci, it was possible to detect
VNTRs between isolates by simply resolving the PCR products
on a 3% agarose gel. Figure 1 demonstrates that there are at
least two alleles for the 6-7, 12-5, 21-3, and 27-5 loci. To
confirm that alleles at a locus varied in size due to VNTRs,
some representative PCR products were sequenced. The data
are summarized in Table 4. In the case of the 18-8 locus, PCR
amplification yielded one distinct product for isolate 4923, but
a staggered ladder was seen for the other isolates. This phe-
nomenon was reproducible. Interestingly, in silico prediction of
the secondary structure of the PCR product revealed a large
hairpin loop containing the repeat region and a Tm of greater
than 70°C. Addition of dimethyl sulfoxide to the PCR mixture
to destabilize the secondary structure alleviated this problem.
The PCR product amplified from isolate 4923 was considerably
shorter than that expected from strain TN. In fact, sequencing
confirmed that there are only three repeats in isolate 4923,
while there are eight in strain TN. This locus could potentially
have several alleles, a desired trait in strain typing.
VNTR polymorphism at four of five microsatellite loci. The
PCR products of the (C)20, (AT)17, (TA)18, and (GTA)9 loci
were resolved on an agarose gel (Fig. 2). There was variation in
the fragment sizes that can be attributed to VNTRs. However,
due to the small size of the repeat unit, it was necessary, as was
done for the minisatellites, to sequence the products directly to
verify the number of repeats. Isolates 4089, 4264, and 4923 had
11, 13 and 15 repeats, respectively, at the (AT)17 locus, cor-
relating well with the mobilities in the agarose gel. There were
only nine C residues at the (C)20 locus in isolate 4923.
We also tested the (AGA)20 locus, which corresponds to the
previously discovered (TTC)21 locus (26), in three of the
armadillo-derived isolates and two biopsy samples obtained
from Leonard Wood Memorial Hospital, Cebu, Philippines,
for VNTRs (Fig. 3). Sequencing revealed that the numbers of
TTC repeats were 12 for isolate 4923, 10 for isolates 4264 and
4089, and 14 for two separate biopsy samples, also in accor-
dance with the migration patterns in the agarose gel. Further
gel migration analysis revealed that a fourth allelic variation
existed within the Thai-53 isolate.
We also amplified the (CG)6 locus and saw no difference
between the different isolates. Furthermore, when the DNA
from strain Thai-53 was sequenced, the number of repeats was
six, as was the case for the TN strain. It therefore seems rea-
sonable that this locus can be eliminated from the list of suit-
able targets. We will, however, refer to this STR as a negative
control and will continue to test it against new, uncharacterized
isolates. From the agarose gel electrophoresis migrations, the
(AC)9 STR may similarly be nonpolymorphic.
Automated MLVA. Microsatellite analysis of the combined
PCR products of the (AT)17, (AGA)20, 6-7, 12-5, and 21-3 loci
of the four isolates, based on PCR and multiplex electrophore-
sis of fluorescently labeled PCR products by automated elec-
trophoresis, yielded patterns that corroborated the findings of
agarose gel electrophoresis. The product sizes were in agree-
ment with the sequence data (Table 4). The ability to distin-
guish the isolates with just five loci demonstrates the potential
of MLVA for molecular typing (Fig. 4). The sensitivity of the
method allows the PCR “stutter” products that occur at mic-
rosatellites (1- to 4-bp repeat units) to be detected and distin-
guished from the main allele peak (34). The (AT)17 locus in
isolate 4264 appeared to contain two alleles, with the major
peak having 13 repeats and another one having 14 repeats.
TABLE 4. PCR product lengths of STR loci in various isolates
Locus
PCR product length (bp)a
TN 4089 4264 4923 Thai-53
(AT)17 181 168 173 177 ND
(C)20 197 ND ND 186 ND
(CG)6 211 211* 211* 211* 211
6-7 268 268* 268 262* 262
12-5 289 289* 289* 277 289
18-8 348 ND ND 258 ND
21-3 312 291 291* 291* 312
27-5 327 ND ND 327* 327
(AGA)20 201 168 168 174 183
a The DNA lengths of the indicated loci were obtained by direct sequencing of
the PCR products. The values for the M. leprae TN strain are based on the
published sequence (14). Values marked with an asterisk were inferred from gel
comparisons (Fig. 1). In addition, for the (CG)6 locus, the entire sequence and
length of product were confirmed after the PCR products were cloned into a
pGEM-T vector (Promega, Madison, Wis.) and sequenced with primers that
annealed to the vector. ND, not determined.
FIG. 1. VNTRs at the minisatellites 6-7, 12-5, 18-8, 21-3, and 27-5 loci in M. leprae. PCR products from M. leprae isolates 4089, 4264, 4923, and
Thai-53 were resolved in that order on a 3% agarose gel. DNA size standards (20-bp ladder) were run in the last lane. The horizontal arrow
indicates the position of the brightest 200-bp size marker. The vertical arrows above the gels indicate that the PCR product was also sequenced.
DMSO, dimethyl sulfoxide.
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Such patterns may become important in assessing the stability
of the marker and the purities of the isolates. For the (AGA)20
locus and minisatellites, minor products differing by 1 bp are
likely due to incomplete 3 dA additions by the polymerase, as
observed in other STR analyses, and could be avoided by
modifying the reverse unlabeled primer (5). As such, these
products do not pose a problem in allele definition for these
loci.
DISCUSSION
Molecular typing methods are frequently based on DNA
sequence differences between isolates which can arise from
single nucleotide changes, deletions and insertions (such as
those arising from mobile elements), and repetitive stretches of
sequences (tandem repetitions) at different sites of a genome.
STR loci, loosely classified as microsatellites (repeat units of
less than 6 bp) or minisatellites (repeat units of 6 to 100 bp),
are excellent sources of polymorphism, because the number of
repeat units can increase or decrease due to slippage of the
DNA strands during replication by the DNA polymerase. The
most recent advance has been in the molecular typing of the
VNTRs by PCR amplification, multiplex electrophoresis, and
automated detection and analyses (29). The digitization of the
data allows the fingerprinting method to be portable and stan-
dardized.
Matsuoka et al. (21) were the first to report on a 6-bp se-
quence present as two alleles within the rpoT gene of M. leprae.
M. leprae isolates from patients in Japan (except Okinawa) and
Korea carried three copies of the repeat unit, while those from
Brazil, Haiti, and Okinawa, Japan, had four copies. The second
influential milestone was the identification of VNTRs of the
TTC triplet in an intergenic region of the genome (26). This
locus is very valuable, because alleles with as few as 10 repeats
and as many as 37 repeats were detected in clinical isolates.
These two lines of experimentation inspired us to initiate a
more thorough and comprehensive analysis of other potential
STRs in M. leprae, because when several independent STR
DNA loci of clinical isolates are evaluated for VNTRs, unique
patterns or fingerprints emerge.
Although this report is limited to data for a small number of
M. leprae isolates propagated in an armadillo, it is significant,
because nine new polymorphic loci have been identified. The
full range of allelic diversity at each locus is not available from
this sample size; even so, this information can now be applied
to the typing of M. leprae isolates from clinical samples (biopsy
and nasal swab specimens) by MLVA. For epidemiological
studies, it is necessary to include a set of reproducible, stable,
and discriminating loci (11, 12). The ability to discriminate
strains can be quantified and is called the discriminatory
power. By analysis of additional isolates and loci, one should
seek a discriminatory power of 0.95 or higher (12).
The MLVA method described here is similar to the method
for the detection of VNTRs in mycobacterial interspersed re-
petitive units in M. tuberculosis isolates (29). The method is
sensitive because PCR with suitable flanking primers is used to
amplify the regions containing the STRs, and small amounts of
genomic DNA are sufficient to amplify several STR loci. This
method has proved to be successful with microorganisms for
which genome sequences have recently become available, such
as Bacillus anthracis (24), Yersinia pestis (17), and Candida
albicans (4). On the basis of this background knowledge, we
have initiated MLVA-based molecular typing for distinguish-
ing strains of M. leprae.
Our long-term vision is to identify a minimal set of typing
markers for a minimal amount of template DNA and the
FIG. 2. VNTRs at the (AT)17, (TA)18, (C)20, and (GTA)9 loci in M. leprae. PCR products from M. leprae isolates 4089, 4264, 4923, and
Thai-53 were resolved on a 3% agarose gel. DNA size standards (20-bp ladder) were run in the rightmost lane, and the brightest band is the 200-bp
size marker. The vertical arrows above the gels indicate that the PCR product was also sequenced.
FIG. 3. VNTR at the (AGA)20 locus in M. leprae obtained from
infected armadillo tissues and frozen sections of two biopsy specimens
(L1 and L2). PCR products for the indicated isolates were resolved on
a 3% agarose gel. The (AGA)20 locus was previously described as the
TTC repeat (26). DNA size standards (100-bp ladder) were run in the
first lane, and the numbers on the left are in base pairs.
1670 GROATHOUSE ET AL. J. CLIN. MICROBIOL.
 o
n








FIG. 4. MLVA analysis of (AT)17, (AGA)20, 12-5, 6-7, and 21-3 loci. (A) Each panel presents the multiplex electrophoresis results for the
(AT)17 (red), (AGA)20 (black), 6-7 (first green peak), 12-5 (second green peak), and 21-3 (blue) fluorescence-labeled PCR products compared
with those of the GeneScan 500LIZ (yellow) size standards obtained on the ABI Prism 3100 Genetic Analyzer. The electropherograms were
obtained with GeneMapper software. The y axis is in fluorescence units, and the x axis is in base pairs. The first four panels contain products from
isolates 4089, 4264, 4923, and Thai-53 (from top to bottom, respectively). Only the (AT)17, 6-7, and 21-3 loci are depicted for the Thai-53 isolate.
The fifth (bottom) panel presents the results for the PCR products from all four isolates combined. (B) An enlarged view of the (AT)17 locus in
the four isolates depicting stutter bands obtained by the PCR. (C) An enlarged view of the 6-7 and 12-5 loci depicting incomplete dA tailing of
the PCR products in isolates 4089, 4264, 4923, and Thai-53 (from top to bottom, respectively).
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optimal analytical conditions applicable to leprosy in the clin-
ical setting. Fixed clinical samples or DNA products may then
be transferred to a reference laboratory for molecular typing
and matched against a database of sequences. Collaborations
are in progress to transfer the methodology.
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